Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

NCT01947608 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer (NSCLC)

Interventions

DRUG: LDK378

Sponsor

Novartis Pharmaceuticals